FDA 483 - RAPHA Health Network International, Inc. - September 09, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
RAPHA Health Network International, Inc. in Doral, FL, a dietary supplement manufacturer, was inspected by the FDA from September 1-9, 2022. The inspection revealed significant deficiencies in their quality control, production, and laboratory operations, indicating a lack of adherence to good manufacturing practices for dietary supplements. Key issues included inadequate batch production records, failure to establish and follow specifications, and uncalibrated laboratory equipment.
ID · 36b1d6e6-f1cd-41c8-a05c-17f1fd713282